Vinegar Test Could Help to Reduce the Incidence of Cervical Cancer

A cheap and simple screening test using the key ingredient in vinegar could help slash incidence of cervical cancer in poor countries, according to a trial conducted in India which is reported in Saturday's Lancet.

Vinegar Test Could Help to Reduce the Incidence of Cervical Cancer

The method entails making a visual inspection of the cervix, using a speculum (a tool to dilate the vaginal walls), a bright halogen lamp and a solution of three- to five-percent acetic acid.

The solution is applied to the cervix, and suspect tissue shows up as whitish lesions. Healthy tissue shows no colour change.

Doctors led by Rengaswamy Sankaranarayanan of the International Agency for Research on Cancer (IARC) in Lyon, France, tested the method on 31,000 women aged 30-59 in the district of Dindigul, in the southern state of Tamil Nadu.

A total of 3,088 women were screened as positive, and were given further examination or a pap smear.

This turned up 1,874 cases of precancerous lesions, 72 percent of whom received treatment.

Over six years, the group recorded a total of 167 cases of cervical cancer and 83 deaths from this disease.

The investigators recruited a "control" group of 31,000 women, who were not screened.

Comparing the two groups, women who had been screened were 25 percent less likely to develop cervical cancer and 35 percent less likely to die from it.

Combined with "good training and sustained quality assurance," the technique is an excellent preventative tool for developing countries, believes Sankaranarayanan.

The vinegar test was pioneered by doctors from Johns Hopkins University in Baltimore, Maryland, who assessed it for safety and effectiveness among 10,000 women in Zimbabwe in 1999. The new trial takes this process a major step further.

There were 493,000 new cases of cervical cancer and 273,000 deaths from the disease in 2002, according to IARC figures quoted in The Lancet paper.

Once the cancer, initiated by the human papilloma virus, spreads beyond the cervix, the chances of survival fall, which means it is vital to spot tumorous cells in the earliest possible stage.

But in poor countries, the pap smear, as well as the newly-introduced cervical cancer vaccine, are often too expensive or unavailable.

Your comments are automatically posted once they are submitted. All comments are however constantly reviewed for spam and irrelevant material (such as product or personal advertisements, email addresses, telephone numbers and website address). Such insertions do not conform to our policy and 'Terms of Use' and are either deleted or edited and republished.Please keep your comments brief and relevant.This section may also have questions seeking help. If you have the information you are welcome to respond, but please ensure that the information so provided is genuine and not misleading.

guest

Great and simple test with universal application that can save many lives. Most cases of cervical cancer in India present very late and results in high mortality and associated complication. I see almost one case with renal failure due to obstruction to ureters caused by the metastatic cancer spread every month in my practise.

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.Full Disclaimer